PTX3 is primarily produced at sites of local inflammation; however, in PCOS follicles, its concentration is significantly lower than in normal ovulatory follicles, which may be linked to hyperandrogenemia and a higher luteinizing hormone (LH)/follicle stimulating hormone (FSH) ratio (130). Here, BRD2 is linked to polycystic ovary syndrome.